Skip to main content

Establishment profile

GOODWIN BIOTECHNOLOGY, INC.

1850 NW 69TH AVENUE, PLANTATION, FL, 33313
325412Pharmaceutical Preparation Manufacturing
EIN 650368262

Download as PDF →

OSHA inspections
1
over 16 years
Violations
6
$2,004 in penalties
Penalties
$2,004
$334 avg

Summary

GOODWIN BIOTECHNOLOGY, INC. has accumulated 6 OSHA violations across 1 inspection over 16 years of recorded history, with $2,004 in total assessed penalties.

The establishment sits in the 87th percentile for violations within its industry-state peer group of 84 employers. The most recent enforcement activity was recorded 16 years ago.

Federal records were found in 1 of 15 sources. Sources without matching records returned empty for this establishment.

Agency coverage

GOODWIN BIOTECHNOLOGY, INC. appears in OSHA workplace safety and OFLC visa and labor certification (historical) records only. No matching records were found in WHD wage enforcement, MSHA mine safety, EPA environmental compliance, NLRB labor relations, FMCSA motor carrier registration, SAM.gov federal debarment, CMS nursing home enforcement, CPSC product recalls, or NHTSA vehicle recalls.

OSHA workplace safety

Inspections
1
0.1 / yr · last 16 yrs
Violations
6
0.4 / yr
Penalties
$2,004
$334 avg / violation
33% serious67% other
Inspection trigger · complaint
1 of 1

100% of inspections at this establishment produced violations,

Most-cited OSHA standards

Top OSHA standards cited at this employer, ranked by citation count. Standards (CFR sections) cluster citations into safety themes -- machine guarding, lockout-tagout, hazard communication, fall protection, process safety, etc. A concentration on one or two sections reveals a pattern that individual citations don’t. 6 distinct standards shown · 6 citations in this view · $2,004 in penalties.

CFR sectionCitationsInspectionsTotal penaltyFirst citedLast cited
29 CFR 1910.0132 D0111$875Mar 2010Mar 2010
29 CFR 1910.0305 B0211$875Mar 2010Mar 2010
29 CFR 1904.0029 A11$254Mar 2010Mar 2010
29 CFR 1910.1200 E01 I11Mar 2010Mar 2010
29 CFR 1910.1200 G0111Mar 2010Mar 2010
29 CFR 1910.1200 H11Mar 2010Mar 2010

Source: OSHA inspection citations (violation_detail). CFR section codes can be looked up at osha.gov/laws-regs for the formal standard text. Per-inspection detail and the specific violation descriptions are available by expanding individual inspections below.

Peer comparison

87th

Worse on violations than most other employers in NAICS 3254 within FL. Peer group: 84 employers. This establishment has 6 OSHA violations; peer median is 1.

Fewer violationsMore violations
Penalty percentile
60th
peer median: $250
Inspection frequency
0th
peer median: 1

Safety self-report (OSHA 300A)

Recordable injury rates the employer filed with OSHA’s Injury Tracking Application. DART covers cases with days away, restricted, or transferred; TRIR is the total recordable case rate.

DART rate
0.0
vs industry
−0.9
TRIR
0.0
vs industry
−1.4

Reported for 70 average annual employees at this establishment.

Source: OSHA ITA Form 300A (employer self-reported). Rates are per 100 full-time equivalent workers. Establishments below the ~10-FTE threshold are not required to report.

Industry benchmark

Industry avg TRIR
1.4
BLS SOII 2024
Industry avg DART
0.9
BLS SOII 2024
Self-reported TRIR
0.0
OSHA ITA Form 300A (employer self-reported)

BLS rates reflect industry-wide averages. Self-reported figures come from OSHA’s Injury Tracking Application; absence of self-reported data does not necessarily indicate non-compliance — many establishments fall below the ITA reporting threshold.

Inspection breakdown

Complaint
1

Complaint- and accident-triggered inspections are stronger risk signals than routine planned inspections.

OSHA severe injury reports

No severe injury reports (hospitalization, amputation, or loss of an eye) on file under 29 CFR 1904.39 for GOODWIN BIOTECHNOLOGY, INC.. Verify directly with Occupational Safety and Health Administration

Activity timeline

Data refreshed
Weekly
First OSHA inspection
Most recent activity
16 years ago

No federal enforcement activity has been recorded against this establishment in 16+ years. Most recent activity: 16 years ago. Data on this page is refreshed weekly.

Wage & Hour Division (WHD)

No WHD wage, overtime, or child-labor enforcement cases on file for GOODWIN BIOTECHNOLOGY, INC.. Verify directly with Wage and Hour Division

Mine safety (MSHA)

No MSHA mine safety violations on file for GOODWIN BIOTECHNOLOGY, INC.. Verify directly with Mine Safety and Health Administration

Labor relations (NLRB)

No NLRB unfair labor practice charges or union representation cases on file for GOODWIN BIOTECHNOLOGY, INC.. Verify directly with National Labor Relations Board

Visa & labor certification (OFLC) — historical

Total applications
1
Certified
1
Avg wage ratio
1.14x
H-1B

Office of Foreign Labor Certification — labor condition applications for H-1B, H-2A, H-2B visa programs. Wage ratio = offered / prevailing wage. Historical data only: DOL ended OFLC Performance Data Disclosure publication in 2026, so the figures above reflect filings through the last ingested cycle and are not being refreshed. Treat as a historical snapshot, not a current signal.

Environmental compliance (EPA)

No EPA inspections or formal enforcement actions on file for GOODWIN BIOTECHNOLOGY, INC.. Verify directly with Environmental Protection Agency

Federal contracts

This location

Obligated (5-yr)
$0
Obligated (all-time)
$284K
Awards
1
Top agency
Department of Health and Human Services
$284K
Company-wide — WALLACE PHARMACEUTICALS PRIVATE LIMITED (across 1 entity)
Obligated (5-yr)
$0
Obligated (all-time)
$284K
Awards (all-time)
1

Consolidated across all USAspending recipient entities under this corporate parent — not attributable to this single location.

Federal contract dollars to this establishment. Primary NAICS: 325414 - BIOLOGICAL PRODUCT (EXCEPT DIAGNOSTIC) MANUFACTURING. Last action: 2008-06-11. Source: USAspending.gov, net obligations. Recipient address is the SAM registration / HQ address, not necessarily the worksite.

Inspection history

DateTriggerViolationsSeriousPenalty
2009-12-07Complaint62$2,004

Source: OSHA IMIS. Citation amounts reflect initially assessed penalties; final amounts after appeal may differ.

In the news

Other employers in this industry and state

Other employers in pharmaceutical preparation manufacturing within FL, ordered by federal enforcement volume:

Related searches

About this data

This profile aggregates federal enforcement records on GOODWIN BIOTECHNOLOGY, INC. from every major federal compliance and enforcement source. OSHA workplace safety inspections, WHD wage cases, MSHA mine safety, EPA environmental enforcement, NLRB labor relations, OFLC visa/labor certification, FMCSA motor carrier registration, SAM.gov debarments, CMS nursing-home records, BLS industry safety benchmarks, OSHA ITA self-reported injury rates, SEC enforcement and financial disclosures, CPSC and NHTSA recalls.

Establishments are matched across agencies using normalized employer name, state, and ZIP code.

OSHA citations typically appear 3–8 months after the inspection, so very recent enforcement actions may not yet be reflected. Profiles may be incomplete if the establishment operates under multiple legal names or files under variations our entity-matching rules don’t yet cover. To report a missing record or correction, email corrections@fastdol.com.

Need API access, bulk download, or licensed redistribution? The website is free. Programmatic and licensed access is handled separately.

Contact sales →

Frequently asked

What is GOODWIN BIOTECHNOLOGY, INC.'s OSHA violation history?
GOODWIN BIOTECHNOLOGY, INC. has 1 OSHA inspection on record with 6 violations and $2,004 in total penalties.
How does GOODWIN BIOTECHNOLOGY, INC.'s safety record compare to its industry?
GOODWIN BIOTECHNOLOGY, INC. operates in the pharmaceutical preparation manufacturing industry. The industry average Total Recordable Incident Rate (TRIR) is 1.4. GOODWIN BIOTECHNOLOGY, INC.'s self-reported DART rate is 0 compared to an industry average of 0.9.